Impact of dynamic contrast-enhanced MRI in 1.5 T versus 3 T MRI for clinically significant prostate cancer detection.

[1]  P. Albers,et al.  MRI grading for the prediction of prostate cancer aggressiveness , 2021, European Radiology.

[2]  P. Albers,et al.  Comparison and prediction of artefact severity due to total hip replacement in 1.5 T versus 3 T MRI of the prostate. , 2021, European journal of radiology.

[3]  K. Iczkowski,et al.  The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. , 2021, The American journal of surgical pathology.

[4]  T. Benkert,et al.  Advanced zoomed diffusion-weighted imaging vs. full-field-of-view diffusion-weighted imaging in prostate cancer detection: a radiomic features study , 2020, European Radiology.

[5]  P. Albers,et al.  Advanced diffusion weighted imaging of the prostate: Comparison of readout-segmented multi-shot, parallel-transmit and single-shot echo-planar imaging. , 2020, European journal of radiology.

[6]  A. Padhani,et al.  Contrast Medium or No Contrast Medium for Prostate Cancer Diagnosis. That Is the Question , 2020, Journal of magnetic resonance imaging : JMRI.

[7]  M. Papotti,et al.  Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI) , 2019, Abdominal Radiology.

[8]  L. Holmberg,et al.  Radical Prostatectomy or Watchful Waiting in Prostate Cancer — 29‐Year Follow‐up , 2018, The New England journal of medicine.

[9]  F. Fennessy,et al.  Investigating the role of DCE-MRI, over T2 and DWI, in accurate PI-RADS v2 assessment of clinically significant peripheral zone prostate lesions as defined at radical prostatectomy , 2018, Abdominal Radiology.

[10]  S. Byun,et al.  Diagnostic performance of diffusion-weighted imaging for prostate cancer: Peripheral zone versus transition zone , 2018, PloS one.

[11]  Tao Peng,et al.  Diagnostic Performance of Biparametric MRI for Detection of Prostate Cancer: A Systematic Review and Meta-Analysis. , 2018, AJR. American journal of roentgenology.

[12]  L. Brunese,et al.  Biparametric MRI of the prostate. , 2017, Turkish journal of urology.

[13]  P. Choyke,et al.  Validation of the Dominant Sequence Paradigm and Role of Dynamic Contrast-enhanced Imaging in PI-RADS Version 2. , 2017, Radiology.

[14]  Fernando Calamante,et al.  Gadolinium deposition in the brain: summary of evidence and recommendations , 2017, The Lancet Neurology.

[15]  P. Albers,et al.  Magnetic resonance imaging of the prostate at 1.5 versus 3.0T: A prospective comparison study of image quality. , 2017, European journal of radiology.

[16]  James S. Babb,et al.  Proposed Adjustments to PI-RADS Version 2 Decision Rules: Impact on Prostate Cancer Detection. , 2017, Radiology.

[17]  M. Parmar,et al.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confi rmatory study , 2018 .

[18]  N. Lumen,et al.  Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA. , 2017, Clinical radiology.

[19]  Katarzyna J Macura,et al.  Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. , 2016, European urology.

[20]  Baris Turkbey,et al.  DCE MRI of prostate cancer , 2016, Abdominal Radiology.

[21]  T. Scheenen,et al.  Multiparametric Magnetic Resonance Imaging in Prostate Cancer Management: Current Status and Future Perspectives , 2015, Investigative radiology.

[22]  David F Kallmes,et al.  Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. , 2015, Radiology.

[23]  T. Sone,et al.  Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging. , 2011, AJR. American journal of roentgenology.

[24]  F. Beuvon,et al.  Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer , 2011, Prostate Cancer and Prostatic Diseases.